최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Clinical and translational radiation oncology, v.20, 2020년, pp.13 - 18
Saito, Hirotake
(Department of Radiation Oncology, Niigata University Medical and Dental Hospital)
,
Shodo, Ryusuke
(Departments of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences)
,
Yamazaki, Keisuke
(Department of Otolaryngology Head and Neck Surgery, Niigata University Medical and Dental Hospital)
,
Katsura, Kouji
(Department of Oral Radiology, Niigata University Medical and Dental Hospital)
,
Ueki, Yushi
(Departments of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences)
,
Nakano, Toshimichi
(Department of Radiology and Radiation Oncology, Niigata University Graduate School of Medical and Dental Sciences)
,
Oshikane, Tomoya
(Department of Radiology and Radiation Oncology, Niigata University Graduate School of Medical and Dental Sciences)
,
Yamana, Nobuko
(Department of Radiation Oncology, Niigata University Medical and Dental Hospital
Abstract Background and purpose Concurrent chemoradiotherapy (CCRT) for head and neck cancer (HNC) is a risk factor for oral candidiasis (OC). As Candida spp. are highly virulent, we conducted a retrospective study to determine whether OC increases the severity of dysphagia related to mucositis in ...
Lancet Oncol Lacas 18 9 1221 2017 10.1016/S1470-2045(17)30458-8 Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis
Radiother Oncol Pignon 92 1 4 2009 10.1016/j.radonc.2009.04.014 Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients
Ann Oncol Nguyen 15 3 383 2004 10.1093/annonc/mdh101 Dysphagia following chemoradiation for locally advanced head and neck cancer
J Clin Oncol Rosenthal 24 17 2636 2006 10.1200/JCO.2006.06.0079 Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer
Lancet Gillison 393 10166 40 2018 10.1016/S0140-6736(18)32779-X Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
J Clin Oncol Noronha 36 11 1064 2018 10.1200/JCO.2017.74.9457 Once-a-week versus once-every-3-weeks cisplatin chemoradiation for locally advanced head and neck cancer: a phase III randomized noninferiority trial
Lancet Oncol Chen 18 6 803 2017 10.1016/S1470-2045(17)30246-2 Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study
J Clin Oncol Feng 28 16 2732 2010 10.1200/JCO.2009.24.6199 Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results
Lancet Oncol Mesia 18 6 704 2017 10.1016/S1470-2045(17)30250-4 HPV-related oropharyngeal carcinoma de-escalation protocols
Int J Radiat Oncol Biol Phys Greco 101 2 421 2018 10.1016/j.ijrobp.2018.01.097 Dysphagia Treatment for Patients With Head and Neck Cancer Undergoing Radiation Therapy: A Meta-analysis Review
Int J Radiat Oncol Biol Phys Dahiya 57 1 79 2003 10.1016/S0360-3016(03)00415-2 Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancer
J Clin Microbiol Redding 37 12 3896 1999 10.1128/JCM.37.12.3896-3900.1999 Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer
Nat Rev Immunol Netea 15 10 630 2015 10.1038/nri3897 Immune defence against Candida fungal infections
Sci Transl Med Brown 4 165 165rv13 2012 10.1126/scitranslmed.3004404 Hidden killers: human fungal infections
Radiother Oncol Busetto 109 2 303 2013 10.1016/j.radonc.2013.05.040 Predictive factors for oropharyngeal mycosis during radiochemotherapy for head and neck carcinoma and consequences on treatment duration. Results of mycosis in radiotherapy (MIR): a prospective longitudinal study
Int J Radiat Oncol Biol Phys Gligorov 80 2 532 2011 10.1016/j.ijrobp.2010.02.006 Prevalence and treatment management of oropharyngeal candidiasis in cancer patients: results of the French CANDIDOSCOPE study
Pract Radiat Oncol Rao 3 3 229 2013 10.1016/j.prro.2012.05.008 Effect of prophylactic fluconazole on oral mucositis and candidiasis during radiation therapy for head-and-neck cancer
Int J Radiat Oncol Biol Phys Sanguineti 83 1 235 2012 10.1016/j.ijrobp.2011.06.2000 Effect of radiotherapy and chemotherapy on the risk of mucositis during intensity-modulated radiation therapy for oropharyngeal cancer
Age Ageing Lacey 46 6 895 2017 10.1093/ageing/afx057 Evidence for strategies that improve recruitment and retention of adults aged 65 years and over in randomised trials and observational studies: a systematic review
Radiother Oncol Zenda 101 3 410 2011 10.1016/j.radonc.2011.09.016 Multicenter phase II study of an opioid-based pain control program for head and neck cancer patients receiving chemoradiotherapy
Aust Dent J Farah 55 Suppl 1 48 2010 10.1111/j.1834-7819.2010.01198.x Oral fungal infections: an update for the general practitioner
Clin Infect Dis Pappas 62 4 e1 2016 10.1093/cid/civ1194 Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
Int J Radiat Oncol Biol Phys Cox 31 5 1341 1995 10.1016/0360-3016(95)00060-C Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)
J Clin Oncol Le 29 20 2808 2011 10.1200/JCO.2010.32.4095 Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study
Int J Radiat Oncol Biol Phys Elting 68 4 1110 2007 10.1016/j.ijrobp.2007.01.053 Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies
Clin Infect Dis Vazquez 42 8 1179 2006 10.1086/501457 A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS
Int J Radiat Oncol Biol Phys Wang 64 3 692 2006 10.1016/j.ijrobp.2005.08.002 Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery
Bone Marrow Transplant Kanda 48 3 452 2013 10.1038/bmt.2012.244 Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Nature Moyes 532 7597 64 2016 10.1038/nature17625 Candidalysin is a fungal peptide toxin critical for mucosal infection
Oral Dis Soysa 14 2 138 2008 10.1111/j.1601-0825.2006.01357.x Antimicrobials as a contributory factor in oral candidosis-a brief overview
Aids Dodd 5 11 1339 1991 10.1097/00002030-199111000-00009 Oral candidiasis in HIV infection: pseudomembranous and erythematous candidiasis show similar rates of progression to AIDS
Oral Surg Oral Med Oral Pathol Oral Radiol Endod Redding 91 6 659 2001 10.1067/moe.2001.112946 Candida dubliniensis in radiation-induced oropharyngeal candidiasis
Am J Med Graybill 104 1 33 1998 10.1016/S0002-9343(97)00307-0 Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patients
Clin Infect Dis Hamza 47 10 1270 2008 10.1086/592578 Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial
Clin Infect Dis Pons 24 6 1204 1997 10.1086/513664 Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions
Cancer Bensadoun 112 1 204 2008 10.1002/cncr.23152
Eur J Cancer Oude Lashof 40 9 1314 2004 10.1016/j.ejca.2004.03.003 An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis
Microbiol Mol Biol Rev Naglik 67 3 400 2003 10.1128/MMBR.67.3.400-428.2003 Candida albicans secreted aspartyl proteinases in virulence and pathogenesis
J Oral Pathol Med Reichart 24 6 276 1995 10.1111/j.1600-0714.1995.tb01182.x Pseudomembranous oral candidiasis in HIV infection: ultrastructural findings
Radiother Oncol Popovtzer 93 3 510 2009 10.1016/j.radonc.2009.05.013 Anatomical changes in the pharyngeal constrictors after chemo-irradiation of head and neck cancer and their dose-effect relationships: MRI-based study
Support Care Cancer Nicolatou-Galitis 14 1 44 2006 10.1007/s00520-005-0835-2 Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.